Inhibiting the colony-stimulating factor 1 receptor (CSF1R) can effectively deplete M2 macrophages and reprogram them toward a pro-inflammatory phenotype, thereby enhancing anti-tumour immunity [64]. This evidence concerns the gene CSF1R and neoplasm.